Q-State Biosciences, Inc. entered into a strategic collaboration with Vertex Pharmaceuticals Inc. to discover drugs using Q-State’s novel Optopatch platform. Under the terms of the deal, Q-State will receive upfront and research support, and is eligible to receive research, development and sales milestones, and royalties on drug sales. The companies will collaborate for at least two years. In the…